Best in Biotech 12 Dec 2023 Five biotech companies based in Dubai you should know about The Middle East’s industry is rapidly growing, with several key players emerging in the region. Notably, Qatar, Saudi Arabia, and the United Arab Emirates (UAE) are at the forefront of this expansion. Our focus today zeros in on the UAE, particularly Dubai and its biotech companies, renowned for being one of the most strategic and […] December 12, 2023 - 7 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 11 Dec 2023 European patents in biotech: how to prevent invalid patents? The ongoing patent battle between COVID-19 vaccine giants, Pfizer-BioNTech and Moderna, has seen a new development when the European Patent Office (EPO) invalidated one of Moderna’s patents related to “respiratory virus vaccines.” BioNTech, in collaboration with Pfizer and Sanofi, opposed the patent, leading to its invalidation. The European patent process is complex but essential. As […] December 11, 2023 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
More News! 4 Dec 2023 FDA CAR-T cell therapy warning: Are T cells malignant? Chimeric antigen receptor (CAR) T cell therapies have emerged as groundbreaking treatments for various hematologic cancers, demonstrating remarkable efficacy in targeting specific cancer cells. However, recent concerns raised by the U.S. Food and Drug Administration (FDA) have sparked an investigation into potential risks associated with these therapies. The FDA CAR-T cell therapy warning comes at […] December 4, 2023 - 4 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 27 Nov 2023 How are R&D Tax Incentives shaping Australia’s biotech future? Research and development (R&D) stands as a cornerstone for driving innovation, particularly within the biotech industry. The pivotal role of R&D extends beyond immediate commercial implications and encompasses a broader spectrum of societal and economic benefits. R&D represents significant expense, and if big companies can afford the risk, it may not be the case for […] November 27, 2023 - 5 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 23 Nov 2023 The next frontier in immunotherapy? CAR-Macrophages as a novel cancer treatment strategy Immunotherapy has revolutionized cancer treatment, offering promising avenues beyond traditional methods. Recent breakthroughs showcased at the Society for Immunotherapy of Cancer’s (SITC) annual meeting have spotlighted innovative approaches, notably chimeric antigen receptor macrophage (CAR-M) therapy, offering new strategies in the fight against solid tumors and addressing the limitations of current treatments. Navigating the labyrinth: immunotherapy’s […] November 23, 2023 - 5 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 17 Nov 2023 With $700 million Q3 rise, U.K. biotech spearheads European recovery The U.K.’s biotechnology landscape has witnessed an impressive surge in funding, clocking a robust £563 million ($700 million) in venture capital and public financings in the third quarter of 2023, according to Biotech Finance. This achievement marks a staggering 48% increase from the previous quarter and sets a formidable pace that is already on track […] November 17, 2023 - 4 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 15 Nov 2023 Beyond oil and gas: Biotech’s significant place in the Qatar Investment Authority’s strategy Since 2020, the Qatar Investment Authority (QIA) has been taking part in important biotech fundings reaching its peak in 2021 and remaining strong in 2023. They recently led a $250 million round in the company BridgeBio specialized in transformative medicine for patients suffering from cancer or genetic diseases. This investment is not an isolated case […] November 15, 2023 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email